Agenda or minutes

UK COVID-19 Therapeutics Advisory Panel: records of decisions

Records of the discussions and decisions in meetings of the UK COVID-19 Therapeutics Advisory Panel (UK-CTAP)

From:
UK-CTAP
Published:

Documents

Details

These are the published records of decisions made by the UK COVID-19 Therapeutics Advisory Panel (UK-CTAP).

UK-CTAP is independent of UK Research and Innovation (UKRI). UKRI has provided secretariat service to the panel throughout its operation.

Some information has been redacted where:

  • the publication of names of pre-approval drugs could impact commercial viability
  • drugs under patent or under development that are submitted by persons who do not own the intellectual property or have commercial interest in the drug.
  • licensed drugs that are still under patent and have commercial interests
  • the information concerns novel formulations of existing drugs
  • the status of the drugs cannot be identified
  • it is protected under the General Data Protection Regulation (GDPR)
  • it is unpublished academic data.

Information has been published where it:

  • is generic with no commercial sensitivity
  • relates to unbranded household foods or substances singularly or in combination
  • is in the public domain either because:
  • it has been recommended for trial
  • the manufacturer has publicly announced their view on efficacy.

Page last updated: 1 June 2022

This is the integrated website of the seven research councils, Research England and Innovate UK.
Let us know if you have feedback or would like to help us test new developments.